Draft Recommendation Statement and Draft Evidence Review: Screening for Hepatitis B in Pregnant Women

Opportunity for Public Comment - US Preventive Services Task Force

Draft Recommendation Statement and Draft Evidence Review:

Screening for Hepatitis B in Pregnant Women

Public Comment on Draft Recommendation Statement and Draft Evidence Review: Screening for Hepatitis B Virus Infection in Pregnant Women The U.S. Preventive Services Task Force seeks comments on a draft recommendation statement and draft evidence review on screening for hepatitis B virus infection in pregnant women. All pregnant women should be screened for hepatitis B at their first prenatal visit. The draft recommendation statement and draft evidence review are available for review and public comment from January 8, 2019 to February 4, 2019 here.

The Draft Recommendation Statement and Draft Evidence Review Are Open to Public Comment

COMMENTING DETAILS

Public Comment Period: 1/8/19 - 2/4/19 Any visitor to the Task Force Web site can comment on any of the listed USPSTF draft documents. However, readers should note that the USPSTF writes these documents for researchers, primary care doctors, and other health care providers, using medical and scientific language as appropriate for these audiences.

DRAFT RECOMMENDATION SUMMARY

Population Recommendation Grade Pregnant woman TThe USPSTF recommends screening for hepatitis B virus infection in pregnant women at their first prenatal visit. A

See the full draft recommendation statement

WHERE WE ARE IN THE PROCESS

Draft Research Plan Final Research Plan Draft Recommendation / Draft Evidence Review Final Recommendation / Evidence Summary